Public Calendar: April 14-20, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 04/16/2019
Location: Washington, DC
Subject: Roundtable on Sharing and Utilizing Health Data for Al Applications
FDA Participant/Group: N/A
Non FDA Participant/Group: Mona Siddiqui,Ed Simcox, Eric Hargan, Kristen Finne (U.S. Department of Health & Human Services); Joel Gurin (The Center for Open Data Enterprise);Sohini Chowdhury (Michael J. Fox Foundation); Jason Jones (Health Catalyst); Vivian Lee (Verily Life Sciences LLC); Lisa Bari (Center for Medicare and Medicaid Innovation Center);Chris Boone (Pfizer Inc.); Tim Persons (U.S. Government Accountability Office)
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Lowell J. Schiller, Principal Associate Commissioner for Polcy
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
Event Date: 04/17/2019
Location: Silver Spring, MD
Subject: FDA-Embassy of Israel Workshop: Digital Health Collaboration
FDA Participant/Group: RAVI BHARWANI, SEMA HASHEMI, RYAN HOSHI, MELISSA TORRES, LEIGH VERBOIS
Non FDA Participant/Group: Shelly Korenboim, Yifat Perel (Embassy of Israel to the United States);
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 04/15/2019
Location: Silver Spring, MD
Subject: Labeling Exemption Meeting
FDA Participant/Group: NINA ZIMDAHL; DOUGLAS STEARN; DOUGLAS TICKER;
Non FDA Participant/Group: Anthony Zografos (SafeTraces, Inc.);
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 04/15/2019
Location: Orlando, FL
Subject: 2019 Muscular Dystrophy Association Clinical and Scientific Conference: CDER's Role
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: N/A
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 04/17/2019
Location: College Park, MD
Subject: Mitigation Strategies to Protect Food Against Intentional Adulteration: Draft Guidance for Industry
FDA Participant/Group: JON-MIKEL WOODY; COLIN BARTHEL; KARI BARRETT; RYAN NEWKIRK; JULIA GUENTHER;
Non FDA Participant/Group: Several respresentatives from the food industry
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 04/18/2019
Location: Rockville, MD
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: MICHAEL MURPHY; TIMOTHY SCHELL; TRACEY FORFA; WILLIAM FLYNN;
Non FDA Participant/Group: David Fairfield, Randy Gordon (National Grain and Feed Association); Joel Newman, Leah Wilkinson (American Feed Industry Association);
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event